The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid
A new agent that subverts myeloma cells from within while also subjecting them to an…